Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$35,101,701
-$2,448,682 QoQ
Shares Held
138,212
-10.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
1.05%
of 13F equity value
Holder Rank
#547
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026World Investment Advisors holds $141,718,806 across 14 Drug Manufacturers - General names. JNJ ranks #1 (24.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
138,212 | $35,101,701 | |
| 2 | LLY |
ELI LILLY & Co
|
25,879 | $31,040,051 | |
| 3 | ABBV |
AbbVie Inc.
|
121,763 | $30,640,441 | |
| 4 | MRK |
Merck & Co., Inc.
|
65,711 | $8,443,863 | |
| 5 | PFE |
Pfizer Inc
|
321,367 | $7,738,517 | |
| 6 | AMGN |
Amgen Inc
|
20,040 | $7,256,884 | |
| 7 | NVS |
Novartis AG
|
44,423 | $6,961,972 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
28,563 | $3,608,649 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,101,701 | 138,212 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $37,550,383 | 153,618 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $33,389,933 | 161,343 | Shares | Sole | 2026-03-13 | |
| 2025-09-30 | $25,011,859 | 134,893 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $20,070,586 | 131,395 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $15,992,117 | 96,431 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $13,727,763 | 94,923 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $13,408,195 | 82,736 | Shares | Sole | 2024-11-25 | |
| 2024-06-30 | $4,176,375 | 28,574 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $852,327 | 5,388 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,815,989 | 11,586 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $316,484 | 2,032 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $321,439 | 1,942 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $299,305 | 1,931 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $342,877 | 1,941 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $355,961 | 2,179 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $438,272 | 2,469 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $448,746 | 2,532 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $452,138 | 2,643 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $382,916 | 2,371 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $364,899 | 2,215 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $393,453 | 2,394 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $375,508 | 2,386 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $374,879 | 2,518 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $342,152 | 2,433 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $334,250 | 2,549 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||